---
figid: PMC4861839__fphys-07-00168-g0001
figtitle: Inositide signaling pathway and target agents used to treat gastric cancer
  and colorectal cancer
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4861839
filename: fphys-07-00168-g0001.jpg
figlink: /pmc/articles/PMC4861839/figure/F1/
number: F1
caption: The inositide signaling pathway and target agents used to treat gastric cancer
  and colorectal cancer. Phosphatidylinosityo-4,5-bisphosphate [PtdIns(4,5)P2] is
  converted to phosphatidylinosityo-3,4,5-triphosphate [PtdIns(3,4,5)P3] by phosphoinositide
  3-kinase (PI3K) as a result of phosphorylation. Akt/PKB is recruited to the plasma
  membrane followed by phosphorylation by mammalian target of rapamycin (mTOR) complex2
  and 3-phosphoinositide-dependent protein kinase 1 (PDK1). Inactivation of tuberous
  sclerosis complex (TSC) 2 by Akt leads to degradation of TSC1/TSC2, which permits
  activation of mTOR. mTOR complex 1 phosphorylates downstream substrates S6 kinase
  1(S6K1) and 4E-binding protein 1(4E-BP1), leading to mRNA translation initiation.
  RTK, receptor tyrosine kinase; GPCR, G-protein coupled receptor.
papertitle: The Inositide Signaling Pathway As a Target for Treating Gastric Cancer
  and Colorectal Cancer.
reftext: Hong Jun Kim, et al. Front Physiol. 2016;7:168.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9612919
figid_alias: PMC4861839__F1
figtype: Figure
redirect_from: /figures/PMC4861839__F1
ndex: 97af2249-dedc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4861839__fphys-07-00168-g0001.html
  '@type': Dataset
  description: The inositide signaling pathway and target agents used to treat gastric
    cancer and colorectal cancer. Phosphatidylinosityo-4,5-bisphosphate [PtdIns(4,5)P2]
    is converted to phosphatidylinosityo-3,4,5-triphosphate [PtdIns(3,4,5)P3] by phosphoinositide
    3-kinase (PI3K) as a result of phosphorylation. Akt/PKB is recruited to the plasma
    membrane followed by phosphorylation by mammalian target of rapamycin (mTOR) complex2
    and 3-phosphoinositide-dependent protein kinase 1 (PDK1). Inactivation of tuberous
    sclerosis complex (TSC) 2 by Akt leads to degradation of TSC1/TSC2, which permits
    activation of mTOR. mTOR complex 1 phosphorylates downstream substrates S6 kinase
    1(S6K1) and 4E-binding protein 1(4E-BP1), leading to mRNA translation initiation.
    RTK, receptor tyrosine kinase; GPCR, G-protein coupled receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - rs
  - Pten
  - Pik3r5
  - Pik3ca
  - Ecm1
  - Ppp1r13b
  - Pdk1
  - Pdpk1
  - Akt1
  - Pik3r1
  - Tsc2
  - Tsc1
  - Mtor
  - Rictor
  - Mapkap1
  - Rptor
  - Akt1s1
  - Rps6kb1
  - GYPC
  - PTEN
  - PIK3R5
  - CUX1
  - SART3
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R6
  - TSC2
  - TSC1
  - CCL26
  - MTOR
  - RICTOR
  - MAPKAP1
  - MLST8
  - RPTOR
  - AKT1S1
  - DLX4
  - EIF4EBP1
  - RPS6KB1
  - Tie
  - Ras85D
  - InR
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Myb
  - Pi3K21B
  - Taf5
  - Akt
  - Pi3K59F
  - Pi3K68D
  - gig
  - Tor
  - rictor
  - Sin1
  - Crtc
  - raptor
  - PRAS40
  - RpS6
  - pie
  - S6k
  - Perifosine
  - Temsirolimus
  - ridaforolimus
  - NVP-BEZ235
  - AZD8055
  - MK-2206
  - Cancer
---
